Bacillus anthracis spore suspensions: determination of stability and comparison of enumeration techniques

Journal of Applied Microbiology
J L AlmeidaK D Cole

Abstract

To determine the stability and variability in concentration of spore suspensions of Bacillus anthracis (BA) spore suspensions by comparing different methods of enumeration and to detect changes, if any, under different storage conditions. Plate and microscope counts were compared to measuring the genomic equivalents based on DNA content BA spore suspensions. We developed chemical methods to extract spore DNA and extra-spore (ES) DNA. DNA mass was determined by gel electrophoresis and QPCR assays were developed using the markers on the chromosome (rpoB) and the pXO1 plasmid (pag). The plate counts and microscope counts were very stable (for up to 900 days). The effect of freezing and the presence of additives in samples were tested for up to 300 days, and the results indicated that the additives tested and freezing did not decrease the viability or microscope counts. Bacillus anthracis spore suspensions can be stored for long periods of time without significant loss of viability or clumping. The content of ES DNA was variable and changed with time. The study shows that BA spore suspensions can be developed for reference materials providing a uniform basis for comparing detection equipment and results from different laboratories.

References

Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Jan 13, 1998·Molecular Microbiology·C MolletD Raoult
Sep 4, 1999·Journal of Applied Microbiology·R OkinakaP Jackson
Oct 12, 1999·Analytical Chemistry·P BelgraderM A Northrup
Jun 1, 1964·Journal of Bacteriology·I TAKAHASHI
Aug 23, 2005·Journal of the Air & Waste Management Association·Jiping ZhuRené Pigeon
Apr 25, 2006·Journal of Applied Microbiology·M P UlrichD A Norwood
Jan 1, 2006·Journal of Research of the National Institute of Standards and Technology·Jamie L AlmeidaKenneth D Cole

❮ Previous
Next ❯

Citations

May 5, 2010·Antimicrobial Agents and Chemotherapy·Linda M WeigelSegaran P Pillai
Dec 6, 2011·Applied and Environmental Microbiology·Paula A KrauterWayne Einfeld
Feb 18, 2016·Journal of Exposure Science & Environmental Epidemiology·Erin E SilvestriTonya L Nichols
Aug 31, 2010·International Journal of Food Microbiology·Martina FrickerMonika Ehling-Schulz
Mar 21, 2012·Molecular Microbiology·Shandee D DixonPhilip C Hanna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.